REIT - Healthcare Facilities
Compare Stocks
5 / 10Stock Comparison
DHC vs OHI vs VTR vs SBRA vs WELL
Revenue, margins, valuation, and 5-year total return — side by side.
REIT - Healthcare Facilities
REIT - Healthcare Facilities
REIT - Healthcare Facilities
REIT - Healthcare Facilities
DHC vs OHI vs VTR vs SBRA vs WELL — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | REIT - Healthcare Facilities | REIT - Healthcare Facilities | REIT - Healthcare Facilities | REIT - Healthcare Facilities | REIT - Healthcare Facilities |
| Market Cap | $1.96B | $13.74B | $41.15B | $5.19B | $149.25B |
| Revenue (TTM) | $1.52B | $1.24B | $6.13B | $813M | $11.63B |
| Net Income (TTM) | $-320M | $632M | $260M | $156M | $1.43B |
| Gross Margin | 2.1% | 85.5% | -4.3% | 63.5% | 39.1% |
| Operating Margin | -2.5% | 64.3% | 13.4% | 29.0% | 4.4% |
| Forward P/E | — | 23.4x | 118.0x | 29.8x | 78.4x |
| Total Debt | $2.42B | $4.26B | $13.22B | $2.55B | $21.38B |
| Cash & Equiv. | $122M | $27M | $741M | $72M | $5.03B |
DHC vs OHI vs VTR vs SBRA vs WELL — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Diversified Healthc… (DHC) | 100 | 226.0 | +126.0% |
| Omega Healthcare In… (OHI) | 100 | 148.1 | +48.1% |
| Ventas, Inc. (VTR) | 100 | 247.6 | +147.6% |
| Sabra Health Care R… (SBRA) | 100 | 152.9 | +52.9% |
| Welltower Inc. (WELL) | 100 | 420.4 | +320.4% |
Price return only. Dividends and distributions are not included.
Quick Verdict: DHC vs OHI vs VTR vs SBRA vs WELL
Each card shows where this stock fits in a portfolio — not just who wins on paper.
DHC is the #2 pick in this set and the best alternative if momentum is your priority.
- +178.4% vs SBRA's +20.5%
OHI carries the broadest edge in this set and is the clearest fit for value and quality.
- Lower P/E (23.4x vs 78.4x)
- 51.0% margin vs DHC's -21.1%
- 6.1% ROA vs DHC's -7.1%, ROIC 6.0% vs -0.7%
VTR ranks third and is worth considering specifically for income & stability and growth exposure.
- Dividend streak 1 yrs, beta 0.01, yield 2.1%
- Rev growth 18.5%, EPS growth 184.2%, 3Y rev CAGR 12.2%
- Beta 0.01, yield 2.1%, current ratio 0.96x
- Beta 0.01 vs DHC's 0.55, lower leverage
SBRA is the clearest fit if your priority is dividends.
- 5.8% yield, vs DHC's 0.5%
WELL is the clearest fit if your priority is long-term compounding and sleep-well-at-night.
- 223.1% 10Y total return vs OHI's 110.0%
- Lower volatility, beta 0.13, Low D/E 49.5%, current ratio 5.34x
- 35.8% FFO/revenue growth vs DHC's 2.8%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 35.8% FFO/revenue growth vs DHC's 2.8% | |
| Value | Lower P/E (23.4x vs 78.4x) | |
| Quality / Margins | 51.0% margin vs DHC's -21.1% | |
| Stability / Safety | Beta 0.01 vs DHC's 0.55, lower leverage | |
| Dividends | 5.8% yield, vs DHC's 0.5% | |
| Momentum (1Y) | +178.4% vs SBRA's +20.5% | |
| Efficiency (ROA) | 6.1% ROA vs DHC's -7.1%, ROIC 6.0% vs -0.7% |
DHC vs OHI vs VTR vs SBRA vs WELL — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
DHC vs OHI vs VTR vs SBRA vs WELL — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
OHI leads in 2 of 6 categories
DHC leads 2 • VTR leads 0 • SBRA leads 0 • WELL leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
OHI leads this category, winning 5 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
WELL is the larger business by revenue, generating $11.6B annually — 14.3x SBRA's $813M. OHI is the more profitable business, keeping 51.0% of every revenue dollar as net income compared to DHC's -21.1%. On growth, WELL holds the edge at +40.3% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $1.5B | $1.2B | $6.1B | $813M | $11.6B |
| EBITDAEarnings before interest/tax | $219M | $1.1B | $2.3B | $432M | $2.8B |
| Net IncomeAfter-tax profit | -$320M | $632M | $260M | $156M | $1.4B |
| Free Cash FlowCash after capex | -$43M | $912M | $1.4B | $367M | $2.5B |
| Gross MarginGross profit ÷ Revenue | +2.1% | +85.5% | -4.3% | +63.5% | +39.1% |
| Operating MarginEBIT ÷ Revenue | -2.5% | +64.3% | +13.4% | +29.0% | +4.4% |
| Net MarginNet income ÷ Revenue | -21.1% | +51.0% | +4.2% | +19.2% | +12.3% |
| FCF MarginFCF ÷ Revenue | -2.8% | +73.6% | +22.4% | +45.1% | +21.9% |
| Rev. Growth (YoY)Latest quarter vs prior year | -5.3% | +16.7% | +22.0% | +20.8% | +40.3% |
| EPS Growth (YoY)Latest quarter vs prior year | -3.8% | +42.4% | 0.0% | -5.9% | +22.5% |
Valuation Metrics
DHC leads this category, winning 3 of 6 comparable metrics.
Valuation Metrics
At 23.8x trailing earnings, OHI trades at a 85% valuation discount to VTR's 160.3x P/E. On an enterprise value basis, OHI's 16.7x EV/EBITDA is more attractive than WELL's 66.4x.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $2.0B | $13.7B | $41.1B | $5.2B | $149.2B |
| Enterprise ValueMkt cap + debt − cash | $4.3B | $18.0B | $53.6B | $7.7B | $165.6B |
| Trailing P/EPrice ÷ TTM EPS | -6.80x | 23.78x | 160.26x | 32.16x | 153.25x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 23.40x | 118.01x | 29.83x | 78.42x |
| PEG RatioP/E ÷ EPS growth rate | — | 1.02x | — | — | — |
| EV / EBITDAEnterprise value multiple | 19.11x | 16.72x | 24.31x | 17.01x | 66.40x |
| Price / SalesMarket cap ÷ Revenue | 1.27x | 11.47x | 7.05x | 6.70x | 13.99x |
| Price / BookPrice ÷ Book value/share | 1.17x | 2.63x | 3.18x | 1.78x | 3.35x |
| Price / FCFMarket cap ÷ FCF | — | 15.64x | 31.25x | 14.89x | 52.41x |
Profitability & Efficiency
OHI leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
OHI delivers a 11.9% return on equity — every $100 of shareholder capital generates $12 in annual profit, vs $-19 for DHC. WELL carries lower financial leverage with a 0.49x debt-to-equity ratio, signaling a more conservative balance sheet compared to DHC's 1.45x. On the Piotroski fundamental quality scale (0–9), WELL scores 7/9 vs SBRA's 5/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | -18.8% | +11.9% | +2.1% | +5.6% | +3.5% |
| ROA (TTM)Return on assets | -7.1% | +6.1% | +1.0% | +2.8% | +2.3% |
| ROICReturn on invested capital | -0.7% | +6.0% | +2.5% | +3.8% | +0.5% |
| ROCEReturn on capital employed | -0.8% | +7.9% | +3.2% | +5.2% | +0.6% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 6 | 6 | 5 | 7 |
| Debt / EquityFinancial leverage | 1.45x | 0.78x | 1.05x | 0.90x | 0.49x |
| Net DebtTotal debt minus cash | $2.3B | $4.2B | $12.5B | $2.5B | $16.3B |
| Cash & Equiv.Liquid assets | $122M | $27M | $741M | $72M | $5.0B |
| Total DebtShort + long-term debt | $2.4B | $4.3B | $13.2B | $2.6B | $21.4B |
| Interest CoverageEBIT ÷ Interest expense | -0.39x | 3.83x | 1.40x | 2.40x | 0.26x |
Total Returns (Dividends Reinvested)
DHC leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in WELL five years ago would be worth $30,234 today (with dividends reinvested), compared to $14,992 for SBRA. Over the past 12 months, DHC leads with a +178.4% total return vs SBRA's +20.5%. The 3-year compound annual growth rate (CAGR) favors DHC at 111.6% vs OHI's 23.0% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +62.9% | +6.6% | +12.6% | +9.0% | +14.3% |
| 1-Year ReturnPast 12 months | +178.4% | +36.9% | +33.9% | +20.5% | +42.7% |
| 3-Year ReturnCumulative with dividends | +847.2% | +86.2% | +94.2% | +113.0% | +189.5% |
| 5-Year ReturnCumulative with dividends | +109.9% | +63.1% | +74.8% | +49.9% | +202.3% |
| 10-Year ReturnCumulative with dividends | -29.5% | +110.0% | +65.0% | +50.9% | +223.1% |
| CAGR (3Y)Annualised 3-year return | +111.6% | +23.0% | +24.8% | +28.7% | +42.5% |
Risk & Volatility
Evenly matched — OHI and VTR each lead in 1 of 2 comparable metrics.
Risk & Volatility
OHI is the less volatile stock with a -0.13 beta — it tends to amplify market swings less than DHC's 0.55 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. VTR currently trades 97.8% from its 52-week high vs OHI's 93.9% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.55x | -0.13x | 0.01x | -0.06x | 0.13x |
| 52-Week HighHighest price in past year | $8.41 | $49.14 | $88.50 | $21.07 | $219.59 |
| 52-Week LowLowest price in past year | $2.80 | $35.09 | $61.76 | $17.08 | $142.65 |
| % of 52W HighCurrent price vs 52-week peak | +96.2% | +93.9% | +97.8% | +97.7% | +97.0% |
| RSI (14)Momentum oscillator 0–100 | 70.1 | 48.6 | 56.2 | 54.5 | 60.2 |
| Avg Volume (50D)Average daily shares traded | 1.9M | 1.9M | 3.4M | 2.1M | 2.6M |
Analyst Outlook
Evenly matched — DHC and SBRA each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: DHC as "Hold", OHI as "Hold", VTR as "Buy", SBRA as "Hold", WELL as "Buy". Consensus price targets imply 17.4% upside for DHC (target: $10) vs 3.0% for SBRA (target: $21). For income investors, SBRA offers the higher dividend yield at 5.75% vs DHC's 0.50%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Hold | Buy | Hold | Buy |
| Price TargetConsensus 12-month target | $9.50 | $49.14 | $90.80 | $21.20 | $226.50 |
| # AnalystsCovering analysts | 17 | 28 | 32 | 29 | 34 |
| Dividend YieldAnnual dividend ÷ price | +0.5% | +5.4% | +2.1% | +5.8% | +1.3% |
| Dividend StreakConsecutive years of raises | 4 | 0 | 1 | 0 | 2 |
| Dividend / ShareAnnual DPS | $0.04 | $2.51 | $1.86 | $1.18 | $2.76 |
| Buyback YieldShare repurchases ÷ mkt cap | +0.1% | 0.0% | 0.0% | 0.0% | 0.0% |
OHI leads in 2 of 6 categories (Income & Cash Flow, Profitability & Efficiency). DHC leads in 2 (Valuation Metrics, Total Returns). 2 tied.
DHC vs OHI vs VTR vs SBRA vs WELL: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is DHC or OHI or VTR or SBRA or WELL a better buy right now?
For growth investors, Welltower Inc.
(WELL) is the stronger pick with 35. 8% revenue growth year-over-year, versus 2. 8% for Diversified Healthcare Trust (DHC). Omega Healthcare Investors, Inc. (OHI) offers the better valuation at 23. 8x trailing P/E (23. 4x forward), making it the more compelling value choice. Analysts rate Ventas, Inc. (VTR) a "Buy" — based on 32 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — DHC or OHI or VTR or SBRA or WELL?
On trailing P/E, Omega Healthcare Investors, Inc.
(OHI) is the cheapest at 23. 8x versus Ventas, Inc. at 160. 3x. On forward P/E, Omega Healthcare Investors, Inc. is actually cheaper at 23. 4x.
03Which is the better long-term investment — DHC or OHI or VTR or SBRA or WELL?
Over the past 5 years, Welltower Inc.
(WELL) delivered a total return of +202. 3%, compared to +49. 9% for Sabra Health Care REIT, Inc. (SBRA). Over 10 years, the gap is even starker: WELL returned +223. 1% versus DHC's -29. 5%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — DHC or OHI or VTR or SBRA or WELL?
By beta (market sensitivity over 5 years), Omega Healthcare Investors, Inc.
(OHI) is the lower-risk stock at -0. 13β versus Diversified Healthcare Trust's 0. 55β — meaning DHC is approximately -529% more volatile than OHI relative to the S&P 500. On balance sheet safety, Welltower Inc. (WELL) carries a lower debt/equity ratio of 49% versus 145% for Diversified Healthcare Trust — giving it more financial flexibility in a downturn.
05Which is growing faster — DHC or OHI or VTR or SBRA or WELL?
By revenue growth (latest reported year), Welltower Inc.
(WELL) is pulling ahead at 35. 8% versus 2. 8% for Diversified Healthcare Trust (DHC). On earnings-per-share growth, the picture is similar: Ventas, Inc. grew EPS 184. 2% year-over-year, compared to -11. 5% for Welltower Inc.. Over a 3-year CAGR, WELL leads at 22. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — DHC or OHI or VTR or SBRA or WELL?
Omega Healthcare Investors, Inc.
(OHI) is the more profitable company, earning 49. 3% net margin versus -18. 6% for Diversified Healthcare Trust — meaning it keeps 49. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: OHI leads at 62. 6% versus -2. 6% for DHC. At the gross margin level — before operating expenses — SBRA leads at 65. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is DHC or OHI or VTR or SBRA or WELL more undervalued right now?
On forward earnings alone, Omega Healthcare Investors, Inc.
(OHI) trades at 23. 4x forward P/E versus 118. 0x for Ventas, Inc. — 94. 6x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for DHC: 17. 4% to $9. 50.
08Which pays a better dividend — DHC or OHI or VTR or SBRA or WELL?
All stocks in this comparison pay dividends.
Sabra Health Care REIT, Inc. (SBRA) offers the highest yield at 5. 8%, versus 0. 5% for Diversified Healthcare Trust (DHC).
09Is DHC or OHI or VTR or SBRA or WELL better for a retirement portfolio?
For long-horizon retirement investors, Omega Healthcare Investors, Inc.
(OHI) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0. 13), 5. 4% yield, +110. 0% 10Y return). Both have compounded well over 10 years (OHI: +110. 0%, DHC: -29. 5%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between DHC and OHI and VTR and SBRA and WELL?
Both stocks operate in the Real Estate sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: DHC is a small-cap quality compounder stock; OHI is a mid-cap income-oriented stock; VTR is a mid-cap high-growth stock; SBRA is a small-cap income-oriented stock; WELL is a mid-cap high-growth stock. OHI, VTR, SBRA, WELL pay a dividend while DHC does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.